Metropolis Healthcare Posts 17% Revenue Growth In Q1 FY27; Specialty Diagnostics & TruHealth Support

Metropolis Healthcare reported revenue of ₹450 crore in the first quarter of FY27, up 17% year-on-year. EBITDA rose 27% to ₹113 crore, while profit after tax increased 26% to ₹57 crore. Patient volumes grew 10% and test volumes 11%, while revenue per patient increased 6%, reflecting a higher contribution from specialised diagnostics.

The diagnostics chain reported growth across both its B2C and B2B businesses, with specialty diagnostics and TruHealth contributing to performance during the quarter. Tier III cities recorded 25% growth, while the company continued to expand its presence in North India and invest in digital initiatives. Business Today TV speaks to Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited, about the company's Q1 performance, expansion plans, trends in the diagnostics industry, digital initiatives and the outlook for FY27.